Qilian International Holding Group Limited
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian S… Read more
Market Cap & Net Worth: Qilian International Holding Group Limited (BGM)
Qilian International Holding Group Limited (NASDAQ:BGM) has a market capitalization of $162.56 Million ($162.56 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #33556 globally and #10954 in its home market, demonstrating a -9.35% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Qilian International Holding Group Limited's stock price $0.90 by its total outstanding shares 180623358 (180.62 Million).
Qilian International Holding Group Limited Market Cap History: 2021 to 2026
Qilian International Holding Group Limited's market capitalization history from 2021 to 2026. Data shows change from $2.32 Billion to $162.56 Million (-53.70% CAGR).
Index Memberships
Qilian International Holding Group Limited is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #847 of 976 |
Weight: Qilian International Holding Group Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Qilian International Holding Group Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Qilian International Holding Group Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
60.81x
Qilian International Holding Group Limited's market cap is 60.81 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $2.32 Billion | $57.10 Million | $3.15 Million | 40.67x | 736.62x |
| 2022 | $647.66 Million | $64.86 Million | $1.08 Million | 9.99x | 601.53x |
| 2023 | $696.30 Million | $46.47 Million | -$7.78 Million | 14.98x | N/A |
| 2024 | $1.53 Billion | $25.10 Million | -$1.44 Million | 60.81x | N/A |
Competitor Companies of BGM by Market Capitalization
Companies near Qilian International Holding Group Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Qilian International Holding Group Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Qilian International Holding Group Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Qilian International Holding Group Limited's market cap moved from $2.32 Billion to $ 162.56 Million, with a yearly change of -53.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $162.56 Million | -75.61% |
| 2025 | $666.50 Million | -56.33% |
| 2024 | $1.53 Billion | +119.20% |
| 2023 | $696.30 Million | +7.51% |
| 2022 | $647.66 Million | -72.11% |
| 2021 | $2.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Qilian International Holding Group Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $162.56 Million USD |
| MoneyControl | $162.56 Million USD |
| MarketWatch | $162.56 Million USD |
| marketcap.company | $162.56 Million USD |
| Reuters | $162.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.